BCR and B-cell chronic lymphocytic leukemia: Therefore, the different strength and persistence of the self-recognition of CLL BcR IGs may influence CLL clinical outcome by modulating the intracellular signal in the pathogenic clones, in turn contributing (at least in part) to the clinical heterogeneity of the disease.